Wiley-Blackwell Medical Overview Medical Library Conference 2008
©2004 Millennium Pharmaceuticals, Inc. © 2004 Millennium Pharmaceuticals Inc. Opportunities and Challenges in Utilizing Biomarkers for Drug Development.
New Paradigms for Clinical Drug Development in the Genomic Era Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute .
Stefano Iacobelli Medical Oncology University G. D’Annunzio, Chieti-Pescara Prognostic and predictive markers and the role of genomics & proteomics.
FDA-Industry-Biomarkers.ppt
Advances and Emerging Therapy for Lung Cancer Rachel E. Sanborn, M.D. Providence Cancer Center.
AGA/ASCO/ASTRO/SSO Gastrointestinal Cancers Symposium Orlando, FL January 26, 2008 Circulating tumor cells: are they predictive markers? Neal J. Meropol,
Biomarkers: challenges or pitfalls for patients Liesbeth Lemmens Digestive oncology University hospitals Leuven.
Identifying Tumors Expressing Predictive Markers: Lessons Learned From HER2
Igniting our potential Health Research Classification System Dr. Ian Viney Medical Research Council (MRC) Director of Strategic Evaluation and Impact MRC.
Mace L. Rothenberg, M.D.
Update on the biology and risk- adapted CLL management in 2013 and the prospect of novel therapies Sami N. Malek, MD Associate Professor Department of.